EASD 2019: Sotagliflozin Improves Glycemic Control and Reduces Weight and SBP in Type 1 Diabetes
The dual SGLT1 and SGLT2 inhibitor addresses several unmet needs in this population.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.